E-Mail Updates

Click here to join
our Electronic Communications.

Listen to our latest webcast
“Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference ”
from October 2nd, 2018

Financial Information

ASX Filing.

Date Price sens. Headline pages PDF
22/10/2018   Annual Report filed on Form 20-F with SEC 127 PDF
11/10/2018   Notice of Annual General Meeting/Proxy Form 27 PDF
11/10/2018   Annual Report to shareholders 80 PDF
11/10/2018   Appendix 4G & Corporate Governance Statement 32 PDF
04/10/2018   Appendix 3B & cleansing notice 15 PDF
02/10/2018   Change of Director's Interest Notice - Mr Chamberlain 3 PDF
02/10/2018   Change of Director's Interest Notice - Mr Meyers 3 PDF
02/10/2018   Appendix 3B & cleansing notice 15 PDF
02/10/2018   Ceasing to be a substantial holder from AEF 3 PDF
02/10/2018   Immutep to present at SITC 2018 2 PDF
28/09/2018   Appendix 3B & cleansing notice 14 PDF
27/09/2018   Appendix 3B & cleansing notice 14 PDF
27/09/2018   Change in substantial holding from AEF 3 PDF
26/09/2018   Immutep to present at Ladenburg Thalmann conference 1 PDF
24/09/2018 ! Immutep enters into collaboration with Pfizer & Merck KGaA 4 PDF
07/09/2018   Immutep presentation for BioCentury NewsMakers conference 29 PDF
03/09/2018   Change in substantial holding from AEF 3 PDF
03/09/2018 ! Progress towards clinical development of IMP761 2 PDF
21/08/2018 ! Appendix 4E & 2018 Full Year Statutory Accounts 82 PDF
21/08/2018 ! Immutep receives A$1.9M from French R&D tax cash rebate 2 PDF
16/08/2018   Immutep to present at BioCentury NewsMakers conference 2 PDF
07/08/2018 ! Immutep secures Canadian patent grant for IMP731 antibody 2 PDF
07/08/2018 ! TACTI-mel Patient Recruitment Complete & Operational Update 3 PDF
31/07/2018 ! Immutep receives IND approval from US FDA for IMP321 2 PDF
30/07/2018 ! Appendix 4C - quarterly 5 PDF
02/07/2018 ! Immutep submits IND application with FDA 2 PDF
19/06/2018   Investor Update 13 PDF
19/06/2018 ! Mid-point of patient enrolment reached in AIPAC trial 2 PDF
04/06/2018   Immutep Poster Presentations at ASCO 2 PDF
30/05/2018 ! Webcast slides for TACTI-mel clinical trial data 25 PDF
30/05/2018 ! New Data from Ongoing TACTI-mel Study 2 PDF
25/05/2018   3rd Annual Advances in Immuno-Oncology Congress Presentation 37 PDF
17/05/2018   Webcast to discuss interim results from TACTI-mel 3 PDF
15/05/2018   Response to ASX Price Query 3 PDF
04/05/2018   Immutep to present at ASCO 2 PDF
23/04/2018   Appendix 4C 5 PDF
13/04/2018   Appendix 3B 13 PDF
13/04/2018   Completion of Share Purchase Plan 2 PDF
03/04/2018 ! Operational Update 2 PDF

 

SEC Filing.

Date Filing Description Link
2018-10-19 20-F Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-302492 (34 Act) Size: 581 KB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300562 (34 Act) Size: 888 KB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300478 (34 Act) Size: 15 MB
PDF
2018-10-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-300442 (34 Act) Size: 247 KB
PDF
2018-10-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-293981 (34 Act) Size: 127 KB
PDF
2018-10-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-292668 (34 Act) Size: 184 KB
PDF-1 PDF-2 PDF-3
2018-10-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-292527 (34 Act) Size: 119 KB
PDF
2018-10-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-291188 (34 Act) Size: 23 KB
PDF
2018-10-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-288121 (34 Act) Size: 118 KB
PDF
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285992 (34 Act) Size: 114 KB
PDF-2
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285992 (34 Act) Size: 114 KB
PDF-1
2018-09-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-285955 (34 Act) Size: 28 KB
PDF
2018-09-10 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-269333 (34 Act) Size: 2 MB
PDF
2018-09-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-266455 (34 Act) Size: 34 KB
PDF
2018-08-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-256678 (34 Act) Size: 1 MB 
PDF-2
2018-08-24 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-256678 (34 Act) Size: 1 MB
PDF-1
2018-08-17 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-251021 (34 Act) Size: 21 KB
PDF
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB 
PDF-2
2018-08-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-241616 (34 Act) Size: 56 KB
PDF-1
2018-08-01 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-233634 (34 Act) Size: 24 KB
PDF
2018-07-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-232248 (34 Act) Size: 108 KB
PDF
2018-07-03 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-211709 (34 Act) Size: 35 KB
PDF
2018-06-20 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-197123 (34 Act) Size: 3 MB
PDF-1
PDF-2
2018-06-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-183678 (34 Act) Size: 34 KB
PDF
2018-05-31 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-179361 (34 Act) Size: 10 MB
PDF-1 PDF-2
2018-05-30 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-177481 (34 Act) Size: 9 MB
PDF
2018-05-18 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-166845 (34 Act) Size: 33 KB
PDF
2018-05-07 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-153820 (34 Act) Size: 32 KB
PDF
2018-04-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-131968 (34 Act) Size: 117 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117066 (34 Act) Size: 21 KB
PDF
2018-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-117059 (34 Act) Size: 115 KB
PDF
2018-04-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Acc-no: 0001193125-18-106513 (34 Act) Size: 29 KB
PDF